¿Cuál es el mejor tratamiento de mantenimiento de la nefritis lúpica tipo IV?

Consequently, there is clearly a need for further well-designed studies of the most recent therapeutic options. Equally, control of cardiovascular risk factors and the use of additional therapies that avoid the adverse effects of these immunosuppressive agents are required to improve the management of patients with type IV lupus nephritis.